World population prospects were presented at the United Nations in 2013 and addressed directly global fertility projections. Fertility rates for many developed countries continue to decline and are projected to do so for the foreseeable future. As part of updating of the WHO Global Guidelines for infertility diagnosis, management and interventions for treatment initiated in January 2012, Guideline Development Groups were assembled. These focus on female subfertility; male subfertility, ovarian stimulation for ART, IVF and ICSI, IUI with and without ovarian stimulation, polycystic ovary syndrome (PCOS); endometriosis, fertility interventions; and environmental effects on fertility, with the call to enhance fertility awareness at the country, if not regional, level.1,2
Substantial educational and practice needs have been identified demonstrating how poor understanding of myriad causes of male and female infertility by clinicians results in their failure to appropriately consider the full value offered to affected women through assisted reproductive technologies (ARTs).
This module addresses for the participant genetic testing for both males and females, also focusing on female infertility anomalies; and describes in detail the roles played by PGD and PGS.